STOCKHOLDERS' EQUITY (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2025	Dec. 31, 2024
Warrants [Abstract]
Outstanding at beginning of period (in shares)	11,045,545
Granted (in shares)	0
Exercised (in shares)	(19,292)
Expired or cancelled (in shares)	0
Outstanding at end of period (in shares)	11,026,253	11,045,545
Exercisable (in shares)	11,026,253
Weighted Average Exercise Price [Abstract]
Outstanding at beginning of period (in dollars per share)	$ 11.5
Granted (in dollars per share)	0
Exercised (in dollars per share)	11.5
Expired or cancelled (in dollars per share)	0
Outstanding at end of period (in dollars per share)	11.5	$ 11.5
Exercisable (in dollars per share)	$ 11.5
Weighted Average Remaining Contractual Life [Abstract]
Outstanding, weighted average remaining contractual life	4 years 25 days	4 years 3 months 21 days
Exercisable, weighted average remaining contractual life	4 years 25 days
Aggregate Intrinsic Value [Abstract]
Outstanding at beginning of period	$ 0
Outstanding at end of period	88,651,074	$ 0
Aggregate intrinsic value, exercisable	$ 88,651,074